Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Please follow the hyperlink “Submit online” on the right and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.
Please use no more than three levels of displayed headings.
Abbreviations should be defined at first mention and used consistently thereafter.
Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables.
Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols.
Always use footnotes instead of endnotes.
Acknowledgments of people, grants, funds, etc. should be placed in a separate section on the title page. The names of funding organizations should be written in full.
Authors must indicate whether or not they have a financial relationship with the organization that sponsored the research. This note should be added in a separate section before the reference list as well as in a separate letter accompanying the manuscript.
If no conflict exists, authors should state: The authors declare that they have no conflict of interest.
• JARO recommends that authors obtain the advice of a statistician prior to starting a study, to aid in the study design. Any statistical analysis must be checked for accuracy by the authors; if statistical software is used, the source (including version number) of the tools must be listed in Materials and Methods; this information should be provided in the final paragraph. Authors are strongly encouraged to seek the assistance of a statistician at their institution or elsewhere; if they seek such advice, the resource should be identified in the letter of submission, and in the acknowledgements.
• Statistics should be fully reported in the manuscript/article. This includes stating the statistical test(s) used, the exact value of N (sample size), and the definitions of the distribution center (mean, median) and measures of variability (SD, SEM, and confidence intervals) reported in the text and shown in figures.
• All legends should include specific "N" for each treatment group and a description (or brief description) of statistics used for each experiment. The definition of a sample should be made clear (N cells, N subjects). If data are pooled from multiple observations on individual subjects, the operations involved in computing the pooled value must be stated.
• Statements that indicate the presence of “significant effects” should be supported by an appropriate statistical test.
• State the type of test that was used, including the degrees of freedom, the resulting test value, and the exact P-value (to 2 significant figures) that the result occurred at chance under the null hypothesis. For t-tests, always state whether the test is for a one-sided or two-sided hypothesis.
• Format: The format of the description of the statistical results should indicate the degrees of freedom, the statistic value, and the P value, as in these examples:
• F (3,21) = 5.62, P = 0.0054
• T(7) = 4.582, P = 0.0025
• r2(9) = 0.77, P = 0.0004
• To avoid ambiguities, all statistical variables should be italicized (F, t, P).
• The type of post-hoc tests used when following any ANOVA with multiple comparisons should be identified.
• Reporting P values with inequalities should be limited to data is grouped in tables or figures, or for post-hoc tests (multiple comparisons) if no exact value is reported by the software.
• Manuscripts that report results based on the analysis of large data sets, including (but not limited to) genomic sequencing studies and fMRI imaging studies are also required to specify in detail how the statistical analyses were done.
Although JARO has word limits on the Abstract, Introduction and Discussion, JARO does not have a page limit or word limits on the Methods and Materials or Results sections. Therefore, the methods and materials should be complete. References to prior methods papers may be made, but only if the original method has been exactly followed, and is completely and clearly described in the prior material. Otherwise, JARO requires that the methods be rewritten (to avoid plagiarism) and be completely described. The purpose of complete methods is to aid in reproducibility and to allow readers to fully understand how the study was done. The following are the guidelines for JARO:
• Methods include all procedures and instructions, manipulations of subject material, selection of subjects, methods used to compute stimuli, versions of programs used, specific hardware, etc. Materials include samples, animal sources and lineage, special storage of key reagents, identification of antibodies by lot, complete primer sequences, etc. The goal of the methods section is to allow studies to be replicated in a lab that is similarly equipped.
• For work that relies on antibodies, the methods section should include information about how antibodies were validated either by citing prior work (for example antibodies listed in the JCN database (http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-9861/homepage/other_resources.htm) or (preferably) in the Antibody Registry (http://antibodyregistry.org). Alternatively, authors may provide a full blot image (not cropped) for each antibody to demonstrate protein specificity, and should include an evaluation of staining in a knock-out animal if possible.
• In animal studies, the methods section should also include relevant information as outlined in the ARRIVE Guideline checklist for Methods (http://www.nc3rs.org.uk/arrive-guidelines). A filled-out copy of the checklist may be included as a supplemental file (not to be published) to aid in the review process.
• The description of data analysis in the methods section should include all processing steps taken to analyze the data (including, but not limited to: additional software filtering, how samples and/or subjects and technical replicates were pooled to determine sample sizes, whether aspects of the experiments were randomized or not, whether the experimenters (and subjects, if relevant) were blinded to subject treatment, and if blinding was used, at what point in the analysis such blinding was unmasked).
• For studies using analysis of images, the analysis section should also include a description of all steps taken while acquiring images, image processing steps prior to analysis, and any additional steps taken in the preparation of images for figures.
• Custom software should be publicly available (for example, on GitHub or a similar repository) or a statement regarding the availability of the software from the authors should be made. Key elements of computational models should be deposited in a database such as ModelDB (https://senselab.med.yale.edu/modeldb/). We also encourage authors to share data in a way that suits the data. Such sharing may include placing the data on a public repository, on a lab web site, or offering to provide the primary data upon request. If work in the manuscript relies on computer simulation code, instructions for providing access to the code for review by both reviewers and readers should be provided.
Cite references in the text by name and year in parentheses. Some examples:
Negotiation research spans many disciplines (Thompson 1990).
This result was later contradicted by Becker and Seligman (1996).
This effect has been widely studied (Abbott 1991; Barakat et al. 1995a, b; Kelso and Smith 1998; Medvec et al. 1999, 2000).
The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text. Do not use footnotes or endnotes as a substitute for a reference list.
Reference list entries should be alphabetized by the last names of the first author of each work. Order multi-author publications of the same first author alphabetically with respect to second, third, etc. author. Publications of exactly the same author(s) must be ordered chronologically.
Gamelin FX, Baquet G, Berthoin S, Thevenet D, Nourry C, Nottin S, Bosquet L (2009) Effect of high intensity intermittent training on heart rate variability in prepubescent children. Eur J Appl Physiol 105:731-738. https://doi.org/10.1007/s00421-008-0955-8
Ideally, the names of all authors should be provided, but the usage of “et al” in long author lists will also be accepted:
Smith J, Jones M Jr, Houghton L et al (1999) Future of health insurance. N Engl J Med 965:325–329
Indicate what graphics program was used to create the artwork.
For vector graphics, the preferred format is EPS; for halftones, please use TIFF format. MSOffice files are also acceptable.
Vector graphics containing fonts must have the fonts embedded in the files.
Name your figure files with "Fig" and the figure number, e.g., Fig1.eps.
Definition: Black and white graphic with no shading.
Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size.
All lines should be at least 0.1 mm (0.3 pt) wide.
Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 1200 dpi.
Vector graphics containing fonts must have the fonts embedded in the files.
Definition: Photographs, drawings, or paintings with fine shading, etc.
If any magnification is used in the photographs, indicate this by using scale bars within the figures themselves.
Halftones should have a minimum resolution of 300 dpi.
Definition: a combination of halftone and line art, e.g., halftones containing line drawing, extensive lettering, color diagrams, etc.
Combination artwork should have a minimum resolution of 600 dpi.
Color art is free of charge for online publication.
If black and white will be shown in the print version, make sure that the main information will still be visible. Many colors are not distinguishable from one another when converted to black and white. A simple way to check this is to make a xerographic copy to see if the necessary distinctions between the different colors are still apparent.
If the figures will be printed in black and white, do not refer to color in the captions.
Color illustrations should be submitted as RGB (8 bits per channel).
To add lettering, it is best to use Helvetica or Arial (sans serif fonts).
Keep lettering consistently sized throughout your final-sized artwork, usually about 2–3 mm (8–12 pt).
Variance of type size within an illustration should be minimal, e.g., do not use 8-pt type on an axis and 20-pt type for the axis label.
Avoid effects such as shading, outline letters, etc.
Do not include titles or captions within your illustrations.
All figures are to be numbered using Arabic numerals.
Figures should always be cited in text in consecutive numerical order.
Figure parts should be denoted by lowercase letters (a, b, c, etc.).
If an appendix appears in your article and it contains one or more figures, continue the consecutive numbering of the main text. Do not number the appendix figures,"A1, A2, A3, etc." Figures in online appendices (Electronic Supplementary Material) should, however, be numbered separately.
Each figure should have a concise caption describing accurately what the figure depicts. Include the captions in the text file of the manuscript, not in the figure file.
Figure captions begin with the term Fig. in bold type, followed by the figure number, also in bold type.
No punctuation is to be included after the number, nor is any punctuation to be placed at the end of the caption.
Identify all elements found in the figure in the figure caption; and use boxes, circles, etc., as coordinate points in graphs.
Identify previously published material by giving the original source in the form of a reference citation at the end of the figure caption.
Figure Placement and Size
Figures should be submitted separately from the text, if possible.
When preparing your figures, size figures to fit in the column width.
For large-sized journals the figures should be 84 mm (for double-column text areas), or 174 mm (for single-column text areas) wide and not higher than 234 mm.
For small-sized journals, the figures should be 119 mm wide and not higher than 195 mm.
If you include figures that have already been published elsewhere, you must obtain permission from the copyright owner(s) for both the print and online format. Please be aware that some publishers do not grant electronic rights for free and that Springer will not be able to refund any costs that may have occurred to receive these permissions. In such cases, material from other sources should be used.
In order to give people of all abilities and disabilities access to the content of your figures, please make sure that
All figures have descriptive captions (blind users could then use a text-to-speech software or a text-to-Braille hardware)
Patterns are used instead of or in addition to colors for conveying information (colorblind users would then be able to distinguish the visual elements)
Any figure lettering has a contrast ratio of at least 4.5:1
Please do not submit figures embedded in PDF or Word .doc/.docx files.
All panels of a given figure should be in a single file.
Top and right axes: Do not include right and top axes unless they are for data that is plotted on a different scale than the opposing axis. Do not box the figure panels with lines.
Frames: Remove ALL frames from around figure panels.
Horizontal and Vertical Gridlines: Horizontal and vertical gridlines should be removed from all graphs/histograms, unless they are there to indicate specific values, or the graph is a 3-D plot, for which such gridlines provide perspective.
Shading: Do not use shaded backgrounds on data plots, except to indicate regions of statistical significance.
Legends: Legends associated with images and plots that indicate the relationship between symbols, line styles, colors, etc. are acceptable. Whenever possible, the legend should be placed so that it fits within the space of the plot. In some cases, the legend information may be better expressed in the figure legend text.
Springer accepts electronic multimedia files (animations, movies, audio, etc.) and other supplementary files to be published online along with an article or a book chapter. This feature can add dimension to the author's article, as certain information cannot be printed or is more convenient in electronic form.
Before submitting research datasets as electronic supplementary material, authors should read the journal’s Research data policy. We encourage research data to be archived in data repositories wherever possible.
Supply all supplementary material in standard file formats.
Please include in each file the following information: article title, journal name, author names; affiliation and e-mail address of the corresponding author.
To accommodate user downloads, please keep in mind that larger-sized files may require very long download times and that some users may experience other problems during downloading.
This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines on how to deal with potential acts of misconduct.
Authors should refrain from misrepresenting research results which could damage the trust in the journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavour. Maintaining integrity of the research and its presentation is helped by following the rules of good scientific practice, which include*:
The manuscript should not be submitted to more than one journal for simultaneous consideration.
The submitted work should be original and should not have been published elsewhere in any form or language (partially or in full), unless the new work concerns an expansion of previous work. (Please provide transparency on the re-use of material to avoid the concerns about text-recycling (‘self-plagiarism’).
A single study should not be split up into several parts to increase the quantity of submissions and submitted to various journals or to one journal over time (i.e. ‘salami-slicing/publishing’).
Concurrent or secondary publication is sometimes justifiable, provided certain conditions are met. Examples include: translations or a manuscript that is intended for a different group of readers.
Results should be presented clearly, honestly, and without fabrication, falsification or inappropriate data manipulation (including image based manipulation). Authors should adhere to discipline-specific rules for acquiring, selecting and processing data.
No data, text, or theories by others are presented as if they were the author’s own (‘plagiarism’). Proper acknowledgements to other works must be given (this includes material that is closely copied (near verbatim), summarized and/or paraphrased), quotation marks (to indicate words taken from another source) are used for verbatim copying of material, and permissions secured for material that is copyrighted.
Important note: the journal may use software to screen for plagiarism.
Authors should make sure they have permissions for the use of software, questionnaires/(web) surveys and scales in their studies (if appropriate).
Authors should avoid untrue statements about an entity (who can be an individual person or a company) or descriptions of their behavior or actions that could potentially be seen as personal attacks or allegations about that person.
Research that may be misapplied to pose a threat to public health or national security should be clearly identified in the manuscript (e.g. dual use of research). Examples include creation of harmful consequences of biological agents or toxins, disruption of immunity of vaccines, unusual hazards in the use of chemicals, weaponization of research/technology (amongst others).
Authors are strongly advised to ensure the author group, the Corresponding Author, and the order of authors are all correct at submission. Adding and/or deleting authors during the revision stages is generally not permitted, but in some cases may be warranted. Reasons for changes in authorship should be explained in detail. Please note that changes to authorship cannot be made after acceptance of a manuscript.
*All of the above are guidelines and authors need to make sure to respect third parties rights such as copyright and/or moral rights.
Upon request authors should be prepared to send relevant documentation or data in order to verify the validity of the results presented. This could be in the form of raw data, samples, records, etc. Sensitive information in the form of confidential or proprietary data is excluded.
If there is suspicion of misbehavior or alleged fraud the Journal and/or Publisher will carry out an investigation following COPE guidelines. If, after investigation, there are valid concerns, the author(s) concerned will be contacted under their given e-mail address and given an opportunity to address the issue. Depending on the situation, this may result in the Journal’s and/or Publisher’s implementation of the following measures, including, but not limited to:
If the manuscript is still under consideration, it may be rejected and returned to the author.
If the article has already been published online, depending on the nature and severity of the infraction:
- an erratum/correction may be placed with the article
- an expression of concern may be placed with the article
- or in severe cases retraction of the article may occur.
The reason will be given in the published erratum/correction, expression of concern or retraction note. Please note that retraction means that the article is maintained on the platform, watermarked “retracted” and the explanation for the retraction is provided in a note linked to the watermarked article.
The author’s institution may be informed
A notice of suspected transgression of ethical standards in the peer review system may be included as part of the author’s and article’s bibliographic record.
Authors have an obligation to correct mistakes once they discover a significant error or inaccuracy in their published article. The author(s) is/are requested to contact the journal and explain in what sense the error is impacting the article. A decision on how to correct the literature will depend on the nature of the error. This may be a correction or retraction. The retraction note should provide transparency which parts of the article are impacted by the error.
Suggesting / excluding reviewers
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts. When suggesting reviewers, authors should make sure they are totally independent and not connected to the work in any way. It is strongly recommended to suggest a mix of reviewers from different countries and different institutions. When suggesting reviewers, the Corresponding Author must provide an institutional email address for each suggested reviewer, or, if this is not possible to include other means of verifying the identity such as a link to a personal homepage, a link to the publication record or a researcher or author ID in the submission letter. Please note that the Journal may not use the suggestions, but suggestions are appreciated and may help facilitate the peer review process.
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to.
The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before the work is submitted.
The Publisher does not prescribe the kinds of contributions that warrant authorship. It is recommended that authors adhere to the guidelines for authorship that are applicable in their specific research field. In absence of specific guidelines it is recommended to adhere to the following guidelines*:
All authors whose names appear on the submission
1) made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work;
2) drafted the work or revised it critically for important intellectual content;
3) approved the version to be published; and
4) agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate).
The decision whether such information should be included is not only dependent on the scope of the journal, but also the scope of the article. Work submitted for publication may have implications for public health or general welfare and in those cases it is the responsibility of all authors to include the appropriate disclosures and declarations.
All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards. Please note that journals may have individual policies on (sharing) research data in concordance with disciplinary norms and expectations. Please check the Instructions for Authors of the Journal that you are submitting to for specific instructions.
Role of the Corresponding Author
One author is assigned as Corresponding Author and acts on behalf of all co-authors and ensures that questions related to the accuracy or integrity of any part of the work are appropriately addressed.
The Corresponding Author is responsible for the following requirements:
ensuring that all listed authors have approved the manuscript before submission, including the names and order of authors;
managing all communication between the Journal and all co-authors, before and after publication;*
providing transparency on re-use of material and mention any unpublished material (for example manuscripts in press) included in the manuscript in a cover letter to the Editor;
making sure disclosures, declarations and transparency on data statements from all authors are included in the manuscript as appropriate (see above).
* The requirement of managing all communication between the journal and all co-authors during submission and proofing may be delegated to a Contact or Submitting Author. In this case please make sure the Corresponding Author is clearly indicated in the manuscript.
Please check the Instructions for Authors of the Journal that you are submitting to for specific instructions regarding contribution statements.
In absence of specific instructions and in research fields where it is possible to describe discrete efforts, the Publisher recommends authors to include contribution statements in the work that specifies the contribution of every author in order to promote transparency. These contributions should be listed at the separate title page.
Examples of such statement(s) are shown below:
• Free text:
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [full name], [full name] and [full name]. The first draft of the manuscript was written by [full name] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
For review articles where discrete statements are less applicable a statement should be included who had the idea for the article, who performed the literature search and data analysis, and who drafted and/or critically revised the work.
For articles that are based primarily on the student’s dissertation or thesis, it is recommended that the student is usually listed as principal author:
The primary affiliation for each author should be the institution where the majority of their work was done. If an author has subsequently moved, the current address may additionally be stated. Addresses will not be updated or changed after publication of the article.
Changes to authorship
Authors are strongly advised to ensure the correct author group, the Corresponding Author, and the order of authors at submission. Changes of authorship by adding or deleting authors, and/or changes in Corresponding Author, and/or changes in the sequence of authors are not accepted after acceptance of a manuscript.
Please note that author names will be published exactly as they appear on the accepted submission!
Please make sure that the names of all authors are present and correctly spelled, and that addresses and affiliations are current.
Adding and/or deleting authors at revision stage are generally not permitted, but in some cases it may be warranted. Reasons for these changes in authorship should be explained. Approval of the change during revision is at the discretion of the Editor-in-Chief. Please note that journals may have individual policies on adding and/or deleting authors during revision stage.
Authors are recommended to use their ORCID ID when submitting an article for consideration or acquire an ORCID ID via the submission process.
Deceased or incapacitated authors
For cases in which a co-author dies or is incapacitated during the writing, submission, or peer-review process, and the co-authors feel it is appropriate to include the author, co-authors should obtain approval from a (legal) representative which could be a direct relative.
Authorship issues or disputes
In the case of an authorship dispute during peer review or after acceptance and publication, the Journal will not be in a position to investigate or adjudicate. Authors will be asked to resolve the dispute themselves. If they are unable the Journal reserves the right to withdraw a manuscript from the editorial process or in case of a published paper raise the issue with the authors’ institution(s) and abide by its guidelines.
Authors should treat all communication with the Journal as confidential which includes correspondence with direct representatives from the Journal such as Editors-in-Chief and/or Handling Editors and reviewers’ reports unless explicit consent has been received to share information.
Upon acceptance of your article you will receive a link to the special Author Query Application at Springer’s web page where you can sign the Copyright Transfer Statement online and indicate whether you wish to order OpenChoice and offprints.
Once the Author Query Application has been completed, your article will be processed and you will receive the proofs.
Authors will be asked to transfer copyright of the article to the Publisher (or grant the Publisher exclusive publication and dissemination rights). This will ensure the widest possible protection and dissemination of information under copyright laws.
Offprints can be ordered by the corresponding author.
Publication of color illustrations is free of charge.
The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title and authorship, are not allowed without the approval of the Editor.
After online publication, further changes can only be made in the form of an Erratum, which will be hyperlinked to the article.
The article will be published online after receipt of the corrected proofs. This is the official first publication citable with the DOI. After release of the printed version, the paper can also be cited by issue and page numbers.
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under the Creative Commons Attribution License.
If you transfer copyright to the Association for Research in Otolaryngology (ARO), then your article will be available to all ARO members and institutional subscribers to JARO for the first year, but not to the public at large until a year has passed. As soon as your article is published in an online issue, Springer will automatically upload your article to PubMed Central with a one year embargo. This procedure will satisfy requirements for research funded by the U.S. National Institutes of Health.
If you do not wish to transfer copyright and/or wish to make your paper freely available before one year after the publication date, you can do so by choosing Springer's "Open Choice" option for $3,000 at the time your article is accepted for publication. In that case the article will also be available immediately in PubMed Central, as well as on SpringerLink.com. See http://www.springer.com/west/home/open+choice?SGWID=4-40359-0-0-0 for further details on this option.
Authors should submit studies that have not been submitted or published elsewhere. Any submitted paper must not currently be under active review at any other journal. Any re-representation of published data must be fully acknowledged and done with the approval of the copyright holder. A statement affirming submission status should be included in the transmittal letter.
Authors are expected to openly declare any commercial interest, or other conflict of interest, when they submit their paper for consideration. This should be done in a letter accompanying the manuscript as well as in the manuscript itself. All authors must have agreed to the content and submission of the final submitted manuscript. Individual email addresses must be provided for all authors so that they may all be contacted should any problem arise.
JARO is a member of NPRC, an alliance of neuroscience journals that have agreed to share manuscript reviews at the author's request. The Consortium’s goals are to support efficient and thorough peer review of original research in neuroscience, to speed the publication of research reports, and to reduce the burden on peer reviewers.
Reviews are only shared with other journals at the corresponding author’s request. They are forwarded directly from one editorial office to another. Normally, the reviewers’ names are forwarded along with the review, because anonymous reviews are generally not useful to editors and will do little to speed the review of manuscripts or reduce the burden on peer reviewers. Nevertheless, reviewers will have the option to not allow their names to be forwarded. As before, reviewers' identities are never revealed to authors.
A related change is that JARO no longer accepts confidential comments to the editors (except to discuss human or animal subject welfare, potential conflicts of interest or misconduct). This way, both authors and editors of journals receiving forwarded reviews will have access to the full review upon which each manuscript decision is based.
Policy and Guidelines on the Sharing of Research Materials and Genetic Database Information
Policy and Guidelines on the Sharing of Research Materials and Genetic Database Information
In general, by submitting a manuscript to the Journal of the Association for Research in Otolaryngology (JARO), the Authors are agreeing to abide by the guidelines stated here concerning sharing of research materials.
In rare instances, considerations of time, money, or personnel, may make sharing of materials impossible. In such a case, the authors must explain the circumstances in a cover letter submitted with the manuscript, indicating that they are prepared to make every effort to assist others in creating their own materials. The Editor-in-Chief of the Journal of the Association for Research in Otolaryngology may then determine on a case-by-case basis whether or not to accept the manuscript for review.
If it is demonstrated to the Editor-in-Chief that an author has failed to abide by these guidelines, the Journal of the Association for Research in Otolaryngology will refuse to publish any manuscript involving that author until the matter is corrected.
Unique materials used in studies being reported in JARO must be made available to qualified scientists for bona fide research purposes.
Before publication, authors must deposit any nucleotide or protein sequence data reported in the manuscript in GenBank or other members of the International Nucleotide Sequence Database Collaboration (EMBL or DDBJ) and SWISS-PROT, and the associated accession numbers must be provided in the article. Similarly, protein or other molecular structure data must be reported in the NCBI Structure database and accession numbers provided in the article.
After publication, authors should be prepared to promptly make available to qualified scientists for bona fide research purposes all materials that were used in the reported research and that were generated in the authors’ laboratories and that are not commercially available. This includes propagatable research materials (such as monoclonal antibodies, transgenic animals, and DNA probes and constructs) and, where possible, non-propagatable materials (for example, serum antibodies). Reasonable costs associated with the production and transfer of these materials should be provided by the recipient if the authors so request.
Such materials should be provided to qualified scientists for bona fide research purposes without restrictions. For example, no restriction may be placed on the kind of research to be done with such materials. Likewise, the person providing the materials should not require future authorship as a condition for this provision.
These guidelines apply to individuals in both the academic and private sectors, except that there is no requirement to provide materials to an individual intending to use them for commercialization.
In some cases, the replication and extension of published work may require materials that are not readily available. In such instances, the authors must make every effort to provide those materials to other qualified scientists. Authors who use materials that they obtain from another source should provide information about that source in the methods.
Authors should try to arrange to provide these materials for a significant period of time after publication.
Authors may, if possible, arrange to distribute materials through entities such as the American Type Culture Collection (Rockville, MD), data banks (e.g., for DNA sequences), or the Jackson Laboratory (Bar Harbor, ME).
For editors and reviewers to accurately assess the work presented in your manuscript you need to ensure the English language is of sufficient quality to be understood. If you need help with writing in English you should consider:
Asking a colleague who is a native English speaker to review your manuscript for clarity.
Visiting the English language tutorial which covers the common mistakes when writing in English.
Using a professional language editing service where editors will improve the English to ensure that your meaning is clear and identify problems that require your review. Two such services are provided by our affiliates Nature Research Editing Service and American Journal Experts. Springer authors are entitled to a 10% discount on their first submission to either of these services, simply follow the links below.
Please note that the use of a language editing service is not a requirement for publication in this journal and does not imply or guarantee that the article will be selected for peer review or accepted.
If your manuscript is accepted it will be checked by our copyeditors for spelling and formal style before publication.
영어 원고의 경우, 에디터 및 리뷰어들이 귀하의 원고에 실린 결과물을 정확하게 평가할 수 있도록, 그들이 충분히 이해할 수 있을 만한 수준으로 작성되어야 합니다. 만약 영작문과 관련하여 도움을 받기를 원하신다면 다음의 사항들을 고려하여 주십시오:
• 귀하의 원고의 표현을 명확히 해줄 영어 원어민 동료를 찾아서 리뷰를 의뢰합니다.
• 영어 튜토리얼 페이지에 방문하여 영어로 글을 쓸 때 자주하는 실수들을 확인합니다.
• 리뷰에 대비하여, 원고의 의미를 명확하게 해주고 리뷰에서 요구하는 문제점들을 식별해서 영문 수준을 향상시켜주는 전문 영문 교정 서비스를 이용합니다. Nature Research Editing Service와 American Journal Experts에서 저희와 협약을 통해 서비스를 제공하고 있습니다. Springer 저자들이 본 교정 서비스를 첫 논문 투고를 위해 사용하시는 경우 10%의 할인이 적용되며, 아래의 링크를 통하여 확인이 가능합니다.